Equine Healthcare Market

Equine Healthcare Market Size - By Product (Vaccines, Pharmaceuticals, Medical Additives, Diagnostics), Indication (Parasite Control, Equine Encephalomyelitis, Equine Influenza), Distribution Channel, Global Forecast, 2023-2032

Published Date: May - 2025 | Publisher: MIR | No of Pages: 240 | Industry: Animal Health and Nutrition | Format: Report available in PDF / Excel Format

View Details Buy Now 2890 Download Free Sample Ask for Discount Request Customization

Equine Healthcare Market Size

Equine Healthcare Market size was approximately USD 1.7 billion in the year 2022 and is anticipated to grow to USD 3.2 billion in 2032 owing to growing demand, investment in the equine racing & sports industry as well as the increasing prevalence of equine disease. The World Organisation for Animal Health (WOAH) report states that equine influenza, equine infectious anaemia, rabies, West Nile fever, and Venezuelan equine encephalomyelitis were some of the prevalent diseases found in 2021.

To get key market trends

  Download Free Sample

Equine care is defined as the technical practice of medical treatment and maintenance specific to equines, which are also generally called equines. Equine care encompasses broad services like check-ups, vaccinations, dental check-ups, diet management, surgery, and treatment of chronic and acute conditions.

Equine Healthcare Market Report Attributes
Report Attribute Details
Base Year 2022
Equine Healthcare Market Size in 2022 USD 1.7 Billion
Forecast Period 2023 to 2032
Forecast Period 2023 to 2032 CAGR 6.4%
2032 Value Projection USD 3.2 Billion
Historical Data for 2018 to 2022
No. of Pages 160
Tables, Charts & Figures 270
Segments covered Product, Indication, Distribution Channel, and Region
Growth Drivers
  • Growing equestrian sports
  • Rising animal health expenditure
  • Increasing support offered by government and public organizations for animal care
Pitfalls & Challenges
  • Shortage of skilled veterinarians

What are the growth opportunities in this market?

 Download Free Sample

COVID-19 Impact

The COVID-19 pandemic seriously negatively impacted the equine healthcare industry. Supply chain disruptions impacted the access to industry including products and services to companion animal health including equine. Lockdowns, social distancing, and mobility restrictions made it difficult for horse owners to attain routine veterinary service care, affecting general health management during the pandemic.

Equine Healthcare Market Trends

The market is poised for progression, driven by increasing various governments and commercial institutions that are investing in animal healthcare infrastructure, recognizing the potential transmission of diseases from animals to humans.

  • Horses are used for recreational purposes quite often, including riding lessons and trail rides. In Minnesota, more than 10% of households go trail riding, and around 8% take riding lessons, which affects horse care expenditure, equipment, and activity fees. This recreational use contributes USD 341 million in additional economic value and creates 7,181 jobs in Minnesota.
  • In addition, the availability of equine medical and diagnostic products and the presence of big veterinary hospitals have also fueled market growth. As an example, the Philip Leverhulme Equine Hospital at the University of Liverpool in North-West England has the latest radiography capable of generating 3D images of bones and soft tissue. Its distinct CT system, with its sliding rack design and high diameter, is the only one on the market for large animal patients in England.
  • Furthermore, the facility provide applications in planning reconstructive surgery and diagnosing conditions related to the head, e.g., head shaking, dental disorders, sinus diseases, and head trauma.

Equine Healthcare Market Analysis

Learn more about the key segments shaping this market

 Download Free Sample

According to product, the market is classified into pharmaceuticals, vaccines, medicinal feed additives, diagnostics, and other products. Pharmaceutical products such as analgesics, anti-infectives, anti-inflammatories, and parasiticides are used in the treatment of several diseases such as reproductive, metabolic, infectious, and dermatological diseases in horses. Pharmaceuticals held the lion's share with a high value of 32.8% in the year 2022.

  • The market for both prescription and non-prescription medications has expanded due to increased spending on equestrian and equine health, driven by the efforts of industry participants. For example, Zoetis offers a wide array of medications, including equine parasiticides like the QUEST gel, Equest Pramox, Deosect 5% Spray Solution, among others.
     
  • Similarly, in December 2022, the U.S. Food and Drug Administration (FDA) granted approval for Zycosan, a Anzac Animal Health LLC product, to manage clinical symptoms linked to osteoarthritis in horses.

Learn more about the key segments shaping this market

 Download Free Sample

Based on indication, the equine healthcare market is classified into musculoskeletal disorders, parasite control, equine herpes, equine encephalomyelitis, equine influenza, tetanus, West Nile Virus, and other indications. The parasite control segment is expected to reach USD 853.5 million by 2032.

  • Parasites, including internal worms and external pests like ticks and flies, can greatly compromise equine well-being, causing a variety of issues, from weight loss through colic to skin irritations.
  • Advances in parasite control products and methods have also driven the growth of this industry. Pharmaceutical manufacturers have developed anthelmintic medications that are more effective and safer, facilitating more targeted and strategic deworming strategies.

Based on distribution channel, the equine healthcare market is classified into veterinary hospital pharmacies, e-commerce, and other distribution channel. The veterinary hospital pharmacies segment accounted for USD 798.3 million in 2022.

  • Veterinary hospital pharmacies and clinics have asserted dominance in the equine healthcare industry due to their central role in providing essential healthcare services and products.
  • These hubs provide an extensive spectrum of medications, therapies, and expert advice for equine health conditions, establishing themselves as the primary choice for horse owners in search of professional healthcare and pharmaceutical remedies.

Looking for region specific data?

 Download Free Sample

The North America equine healthcare market is expected to grow at 6.2% by 2032.
 

  • The existence of horse farms and the yearly horse racing activities greatly bring about the overall equine population in the area. Increasing equine disease cases have driven the business. For example, as noted by a journal article published in National Center for Biotechnology Information (NCBI), eastern equine encephalitis (EEE) is one of the most dangerous arboviral encephalitis diseases in the U.S. It is presently classified as an emerging disease, with its steady increase in reported cases in a larger population. It is observed that every year, between six to eight cases are reported by the U.S., mostly in May to October, and most commonly seen in states like Florida, Georgia, Maryland, Wisconsin, and New Jersey.

Equine Healthcare Market Share

The sector entails high competition, with industry players and major players endeavoring to adopt strategic initiatives. These involve enhancing their product portfolio, launching upgraded Vetoquinol , establishing partnerships, increasing their presence in new markets, and acquiring other players. Zoetis, Vetoquinol and Boehringer hold substantial market share within the overall sector.

Market players operating in the market is as mentioned below

  • Zoetis
  • Boehringer Ingelheim International GmbH
  • MERCK & CO., INC.
  • Vetoquinol S.A.
  • Ceva
  • Hallmarq Veterinary Imaging
  • SOUND
  • ESAOTE SPA
  • Dechra Pharmaceuticals PLC
  • IDEXX Laboratories, Inc.
  • Sante Animale

Equine healthcare Industry News

  • In September 2022, Zoetis acquired NewMetrica, a animal health research institute. The acquisition aimed to develop innovative approach for transitioning veterinary care and animal welfare on a broader scale, emphasizing the achievement of high-quality or exceptional life standards for companion animals.
  • In April 2022, Boehringer Ingelheim International GmbH launched renuTend, a novel stem cell therapy designed to enhance the healing of tendon and suspensory ligament injuries in horses. The introduction of this product provides veterinarians with a fresh therapeutic choice for addressing injuries related to tendons and suspensory ligaments. This strategy enabled company to add value to its existing portfolio and generate revenue from its sales.

The equine healthcare market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments

Click here to Buy Section of this Report

By Product, 2018 – 2032 (USD Million)

  • Vaccines
  • Pharmaceuticals
  • Parasiticides
    • Anti-Infective
    • Anti-Inflammatory & Analgesics
    • Other pharmaceuticals
  • Medicinal Feed Additives
  • Diagnostics
  • Other products

By Indication, 2018 – 2032 (USD Million)

  • Musculoskeletal disorders
  • Parasite control
  • Equine herpes
  • Equine encephalomyelitis
  • Equine influenza
  • Tetanus
  • West Nile Virus
  • Other indications

By Distribution Channel, 2018 – 2032 (USD Million)

  • Veterinary hospital pharmacies
  • E-commerce
  • Other distribution channels

The above information is provided for the following regions and countries

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of Middle East & Africa

 

Related Reports

Table of Content

  • Executive Summary
    1.1. Market Overview
    1.2. Key Findings
    1.3. Strategic Recommendations

  • Market Introduction
    2.1. Definition and Scope
    2.2. Research Methodology
    2.3. Market Segmentation

  • Market Dynamics
    3.1. Drivers
    3.2. Restraints
    3.3. Opportunities
    3.4. Challenges
    3.5. Industry Trends

  • Equine Healthcare Market Overview
    4.1. Market Size and Forecast (by Value & Volume)
    4.2. Market Share Analysis
    4.3. Porter’s Five Forces Analysis
    4.4. Value Chain Analysis

  • Market Segmentation
    5.1. By Product Type
        • Pharmaceuticals
        • Vaccines
        • Nutritional Supplements
        • Diagnostics
        • Medical Devices
    5.2. By Indication
        • Musculoskeletal Disorders
        • Infectious Diseases
        • Digestive Disorders
        • Others
    5.3. By Distribution Channel
        • Veterinary Hospitals & Clinics
        • Retail Pharmacies
        • Online Pharmacies

  • Regional Analysis
    6.1. North America
    6.2. Europe
    6.3. Asia-Pacific
    6.4. Latin America
    6.5. Middle East & Africa

  • Competitive Landscape
    7.1. Market Share Analysis – Key Players
    7.2. Company Profiles
        • Zoetis Inc.
        • Boehringer Ingelheim
        • Merck & Co., Inc.
        • Ceva Santé Animale
        • Dechra Pharmaceuticals PLC
        • Others

  • Recent Developments
    8.1. Mergers & Acquisitions
    8.2. Product Launches
    8.3. Strategic Collaborations

  • Future Outlook and Forecast (2025–2030)
    9.1. Market Projections
    9.2. Investment Opportunities
    9.3. Technological Advancements

  • Appendix
    10.1. Acronyms
    10.2. References
    10.3. Research Methodology Overview

Will be Available in the sample /Final Report. Please ask our sales Team.

FAQ'S

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@marketinsightsresearch.com

Within 24 to 48 hrs.

You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email